Table 2.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
HR | 95% CI | Adjusted HR* | 95% CI | |
Disease | ||||
pSS | 1.338*** | (1.215–1.472) | 1.246*** | (1.123–1.384) |
Gender | ||||
Female (ref.) | 1.000 | 1.000 | ||
Male | 2.130*** | (1.860–2.440) | 0.865 | (0.762–0.982) |
Age group | ||||
≤60 (ref.) | 1.000 | 1.000 | ||
61–70 | 20.51*** | (16.98–24.78) | 17.06*** | (14.04–20.73) |
71–80 | 57.00*** | (47.42–68.54) | 42.30*** | (34.78–51.44) |
>80 | 102.2*** | (82.89–126.1) | 77.73*** | (62.59–96.54) |
Comorbidities | ||||
Diabetes | 3.762*** | (3.319–4.263) | 1.608*** | (1.431–1.808) |
Hyperlipidemia | 2.011*** | (1.781–2.270) | 0.958 | (0.853–1.075) |
Hypertension | 5.198*** | (4.677–5.778) | 1.353*** | (1.216–1.505) |
Heart failure | 3.650*** | (2.858–4.662) | 0.914 | (0.719–1.161) |
Cardiovascular disease | 2.615*** | (2.351–2.908) | 1.380*** | (1.247–1.526) |
Stroke | 5.159*** | (4.539–5.863) | 1.755*** | (1.549–1.990) |
Major psychosis or a substance‐related disorder | 3.414*** | (2.860–4.076) | 3.296*** | (2.811–3.865) |
Traumatic brain injury | 3.067*** | (2.150–4.376) | 1.556 | (1.145–2.114) |
Adjusted HR*: adjusted by age groups, gender, and the comorbidities.
*P value for HR <0.05, **P value for HR <0.01, ***P value for HR <0.001.